| Abstrakt: |
A recent report discusses the advancements in cancer research conducted by the U.S. Food and Drug Administration (FDA). The FDA, in collaboration with the American Association for Cancer Research, launched the FDA-AACR Oncology Educational Fellowship, a year-long program aimed at hematology/oncology fellows, scientists, and early-career investigators. The program provides an in-depth exploration of the regulatory review process and has received positive feedback from participants. The report reflects on the experiences of four alumni, highlighting the program's impact on diverse oncology career paths in government, academia, and industry. [Extracted from the article] |
